{"name":"Maoxiang Group Jilin Pharmaceutical Co., Ltd.","slug":"maoxiang-group-jilin-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Acetaminophen tablets","genericName":"Acetaminophen tablets","slug":"acetaminophen-tablets","indication":"Mild to moderate pain","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Fang yi qing feng shi granule","genericName":"Fang yi qing feng shi granule","slug":"fang-yi-qing-feng-shi-granule","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Acetaminophen tablets","genericName":"Acetaminophen tablets","slug":"acetaminophen-tablets","phase":"marketed","mechanism":"Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system.","indications":["Mild to moderate pain","Fever reduction"],"catalyst":""},{"name":"Fang yi qing feng shi granule","genericName":"Fang yi qing feng shi granule","slug":"fang-yi-qing-feng-shi-granule","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_2":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}